Learn
Patient Navigation Program
Expanded Access Programs
Brain Tumor Symptoms
Guide For High Grade Tumors
Guide For Low Grade Tumors
Checklist For Newly Diagnosed
Video Library
Noteworthy Treatments & Tips
Brain Tumor News
Survivor Stories
Fundraising
DC-Vax
Modeyso™(Onc-201) for DIPG/DMG
Optune
Temodar (Temozolomide)
GammaTile
Newsletter
Subscribe
Change Email
Unsubscribe
Archives
Virtual Trial
What is it?
Join
Submit An Update
Map of Participants
Resources
Copayment Assistance Program
Drug Discount Card
Clinical Trial Search
Brain Tumor Centers
Support Groups
Links To Other Resources
Books
Memorials
About Us
Musella Foundation
Research Grants
Recent Additions To Website
Privacy Policy
Ethics And Values
Our Sponsors
Financials
Contact
donations
Sponsored by
Please click on the above banner for more details
Brain Tumor News
Brain Tumor Conferences / Events
Brain Tumor News!
Subscribe to our Free Brain Tumor News Blast E-Mail Newsletter
Brain Tumor News Blast Archives
Submit a press release or abstract
Recent additions to this website!
Brain Tumor News!
Note: The comments under each article title are the
opinion
of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 5310 to 5329 of 7,812
Previous 20
Next 20
06/08/04
Prospective NCCTG quality of life (QOL) study in adult newly diagnosed high-grade gliomas (HGG).
06/08/04
Radiotherapy and concomitant weekly carboplatin and daily etoposide for patients with inoperable biopsy proven glioblastoma multiforme.
06/08/04
Second line BCNU plus CPT-11 chemotherapy in recurrent glioblastoma (GBM): Phase II study of GICNO (Italian Neuro-Oncology Group).
06/08/04
Specific therapy for high-grade glioma by convection-enhanced delivery of the TGF-β2 specific antisense oligonucleotide AP 12009.
06/08/04
Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study.
06/08/04
Temozolomide combined with radiation as first-line treatment in primary glioblastoma multiforme: Phase I/II-study.
06/08/04
Temozolomide for the treatment of recurrent glioma: Results of a compassionate use program in Belgium.
06/08/04
The familiality of primary brain tumors as studied in the Utah Population Database (UPDB).
06/08/04
Updated results from NABTT CNS consortium studies in primary CNS lymphoma.
06/08/04
Drug treatment is first major improvement in brain cancer in decades
06/08/04
Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.
06/08/04
Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience.
06/08/04
Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas.
06/08/04
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
06/08/04
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
06/08/04
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study.
06/08/04
The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors.
06/08/04
Histopathological findings in autopsied glioblastoma patients treated by mixed neutron beam BNCT.
06/08/04
A phase I/II trial of BMS-247550 for patients with recurrent high-grade gliomas.
06/08/04
A phase I/II trial of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with either temozolomide or lomustine for patients with recurrent glioblastoma multiforme (GBM).
Displaying Stories 5310 to 5329 of 7812
Previous 20
Next 20
Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!